[Anesthesia for coronary revascularization in patients with Kawasaki disease: case report]

Area of Science:

• Pediatric Cardiology
• Immunology
• Vascular Biology

Background:

• Kawasaki disease is a leading cause of acquired heart disease in children.
• Characterized by coronary artery lesions, particularly aneurysms, its etiology remains unknown.
• Genetic predisposition and immune responses to microbial agents are hypothesized causes.

Observation:

• The condition predominantly affects infants and young children, with a higher incidence in Asian populations.
• While surgical techniques for coronary artery complications are documented, anesthetic management is less described.
• This study details the anesthetic approach for a patient undergoing coronary artery bypass graft for Kawasaki disease complications.

Findings:

• High-dose intravenous immunoglobulin and acetyl salicylic acid are primary treatments.
• These treatments reduce coronary artery aneurysm risk from 25% to 4%.
• Percutaneous coronary interventions and coronary artery bypass graft are options for myocardial ischemia.

Implications:

• Understanding anesthetic management is crucial for pediatric patients with Kawasaki disease requiring cardiac surgery.
• Further research into anesthetic techniques can improve perioperative outcomes.
• This work highlights the need for specialized anesthetic protocols in managing complex pediatric cardiovascular conditions.